Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.73

+1.7%

Nov 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tomato who wrote (825)	2/16/2005 11:14:21 PM
From: Jibacoa	Read Replies (1) of 3722

MUCL, one of the two subsidiary companies of Extent Ind., was up 10.53% as it was able to close above its Feb. & Jan. Hs. The volume of 2,731,904 was the highest in many months and larger than the 1,800,293 traded on Jan.11 The stock has been on a near term up-trend since Jan.5 when the up-move started from the $0.20 level.<g> The stock, as well as ASTM's, have been benefiting by the fact that ASCs are not affected by the recent setbacks on ESCs. (It is expected that the demand for ASCs will increase after stem cell experts said recently that all federally approved lines of ESCs are contaminated with a non-human molecule that could be tumorogenic.<g>) biz.yahoo.com For the 9 months MUCL's revenues reportedly increased 82% to $534Ks, but its loss increased to $3.2M from $1.2M in 2003.<g> In spite of its $0.01 cash/share, it has a Debt/Equity ratio of 0.324 <g>(Insiders reportedly hold around 35% of the shares.) The stock needs to close above its early Apr. H of $0.48 before it can test its Mar. H at $0.56 or its Feb. H at $0.68 but at any rate, it is up a 100% so far in 2005.<g> bigcharts.marketwatch.com bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next